Physician global assessments or blood tests do not predict mucosal healing in ulcerative colitis - Wikidata - awgldk - TriplyDB

Physician global assessments or blood tests do not predict mucosal healing in ulcerative colitis

Physician global assessments or blood tests do not predict mucosal healing in ulcerative colitis

http://www.wikidata.org/entity/Q33810986

about

Golimumab for the treatment of ulcerative colitis.Histological healing after infliximab induction therapy in children with ulcerative colitis The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease.Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis.Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease: A Systematic Review and Practical Guide.Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease.Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients?

P2860

Q33852257-FCE4DED6-C9B3-4A8A-BB60-23DDD63442E3 Q36105637-204B6F2E-50A3-441A-8545-28E83D679F3C Q37329989-4274E795-3021-4D64-A442-C78D8877DCAB Q37387994-3599108B-A13F-4DB3-BF9D-4A642669154E Q38782416-4425D782-C84A-42BC-A413-E779A016FD76 Q38789632-B02D1093-EABF-4847-8CAF-0AB463B11185 Q48178445-2BF18042-E54D-4C8B-90B1-61E992CB84BB

P2860

Physician global assessments or blood tests do not predict mucosal healing in ulcerative colitis

http://www.wikidata.org/entity/Q33810986

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Physician global assessments o ...... healing in ulcerative colitis

@ast

Physician global assessments o ...... healing in ulcerative colitis

@en

type

label

Physician global assessments o ...... healing in ulcerative colitis

@ast

Physician global assessments o ...... healing in ulcerative colitis

@en

prefLabel

Physician global assessments o ...... healing in ulcerative colitis

@ast

Physician global assessments o ...... healing in ulcerative colitis

@en

P1433

Q33810986-79B28F1A-BD9B-4FF1-9E29-F4633942F09B

P1476

Q33810986-CD7345E4-DBA7-47A6-83E6-11838E1F7054

P2093

Q33810986-3D758878-8BFD-42C6-9E59-E59730278E13

Q33810986-BF9C82DF-9ADC-4760-B2D1-B52508E02578

P2860

Q33810986-1DD7606D-855F-4FF6-9690-D94A7867440F

Q33810986-3DA8CD43-5B91-4B90-8CB6-652972E4FE9A

Q33810986-3F63C3E2-9D64-4E8C-91F8-492E68EA25C3

Q33810986-5512119F-DCC3-400F-BC70-AC8E630B6DEC

Q33810986-69AD34E4-486F-4755-BF7C-D7DAE273AD4A

Q33810986-6CA401A9-F8D9-4A4D-ACDF-6909227F0A85

Q33810986-7BD25870-1687-46B3-8AA8-92504E14BAB2

Q33810986-854C9376-312F-4C43-BA04-301550C5B717

Q33810986-8F2E362A-C36F-43E4-896A-156B49405B47

Q33810986-8F501C28-FC7C-479F-89E9-5152F816B3A1

P304

Q33810986-CB9229E5-24F6-4FCF-9DD9-06796D814B87

P31

Q33810986-753BBF34-D1CC-4241-9C42-67E7E6CAA982

P356

Q33810986-C6A9399A-08EA-4BBF-BB38-1B67DBC7ABBD

P407

Q33810986-25791419-35D5-451B-A4DD-3FD1F129F633

P433

Q33810986-7AA73345-B65A-4F33-AC19-A1AD835A4CEC

P478

Q33810986-9A5A063B-3675-41A8-B35B-117E6276130B

P577

Q33810986-0D438162-CDFA-47E2-9906-8D83051E8D84

P5875

Q33810986-98E35FA5-1D5D-4989-8A96-11F7E283AE63

P698

Q33810986-F2AC2C60-663C-45F8-BB36-572CC445EDF4

P932

Q33810986-38AFDA40-F706-4F49-9A0F-6BFD14E2D406

P356

P1433

Canadian Journal of Gastroenterology & Hepatology

P1476

Physician global assessments o ...... healing in ulcerative colitis

@en

P2093

Charles N Bernstein

http://www.w3.org/2001/XMLSchema#string

Mayur Brahmania

http://www.w3.org/2001/XMLSchema#string

P2860

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice.

Laboratory markers in IBD: useful, magic, or unnecessary toys?

A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.

Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?

The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease.

Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease.

Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort.

A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis.

P304

325-329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/737349

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263295352

http://www.w3.org/2001/XMLSchema#string

P698

24945187

http://www.w3.org/2001/XMLSchema#string

P932

4072234

http://www.w3.org/2001/XMLSchema#string